These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 3542803

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.
    Sibert JR, Harper PS, Thompson RJ, Newcombe RG.
    Arch Dis Child; 1979 Jul; 54(7):534-7. PubMed ID: 485196
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy.
    Thompson MW, Murphy EG, McAlpine PJ.
    J Pediatr; 1967 Jul; 71(1):82-93. PubMed ID: 5293863
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The use of concomitant serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) for carrier detection in Duchenne's muscular dystrophy through discriminant analysis.
    Zatz M, Otto PA.
    J Neurol Sci; 1980 Sep; 47(3):411-7. PubMed ID: 7420115
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV, Labeznik TA, Shilov LA.
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [Abstract] [Full Text] [Related]

  • 14. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination.
    Percy ME, Andrews DF, Thompson MW.
    Am J Med Genet; 1981 Jan; 8(4):397-409. PubMed ID: 7246612
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait.
    Goldsmith BM, Gruemer HD, Hawley RJ, Pickard NA, Verrill HL, Nance WE, Miller G, Crawford RG.
    Clin Chem; 1980 May; 26(6):754-9. PubMed ID: 7371153
    [Abstract] [Full Text] [Related]

  • 18. Quantitative EMG and histological carrier detection of Duchenne muscular dystrophy.
    Scarlato G, Valli G, Meola G, Carenini L.
    J Neurol; 1977 Nov 01; 216(4):235-49. PubMed ID: 72807
    [Abstract] [Full Text] [Related]

  • 19. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker).
    Zatz M, Shapiro LJ, Campion DS, Kaback MM, Otto PA.
    J Neurol Sci; 1980 Jun 01; 46(3):267-79. PubMed ID: 7381516
    [Abstract] [Full Text] [Related]

  • 20. Needle muscle biopsy for carrier detection in Duchenne muscular dystrophy. Part 1. Light microscopy--histology, histochemistry and quantitation.
    Maunder-Sewry CA, Dubowitz V.
    J Neurol Sci; 1981 Feb 01; 49(2):305-24. PubMed ID: 6452514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.